{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:02:55Z","timestamp":1787241775914,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T00:00:00Z","timestamp":1563840000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Belgian Fund for Scientific Research"},{"name":"Fondation contre le cancer"},{"name":"FIRS CHU Liege"},{"DOI":"10.13039\/501100006673","name":"Fonds L\u00e9on Fredericq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12967-019-1984-2","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T09:06:33Z","timestamp":1563872793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Tryptophan catabolism increases in breast cancer patients compared to healthy controls without affecting the cancer outcome or response to chemotherapy"],"prefix":"10.1186","volume":"17","author":[{"given":"Concetta Elisa","family":"Onesti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Boemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0315-3718","authenticated-orcid":false,"given":"Claire","family":"Josse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Leduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bours","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Jerusalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,23]]},"reference":[{"issue":"21","key":"1984_CR1","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1158\/0008-5472.CAN-12-0569","volume":"72","author":"M Platten","year":"2012","unstructured":"Platten M, Wick W, Van den Eynde BJ. Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. Cancer Res. 2012;72(21):5435\u201340.","journal-title":"Cancer Res"},{"issue":"15","key":"1984_CR2","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.1158\/0008-5472.CAN-07-1872","volume":"67","author":"R Metz","year":"2007","unstructured":"Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound d-1-methyl-tryptophan. Cancer Res. 2007;67(15):7082\u20137.","journal-title":"Cancer Res"},{"key":"1984_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1756-6606-2-8","volume":"2","author":"M Kanai","year":"2009","unstructured":"Kanai M, Funakoshi H, Takahashi H, Hayakawa T, Mizuno S, Matsumoto K, et al. Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol Brain. 2009;2:8.","journal-title":"Mol Brain."},{"issue":"12","key":"1984_CR4","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.4161\/cbt.12.12.18142","volume":"12","author":"MY Chang","year":"2011","unstructured":"Chang MY, Smith C, DuHadaway JB, Pyle JR, Boulden J, Soler AP, et al. Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenase. Cancer Biol Ther. 2011;12(12):1050\u20138.","journal-title":"Cancer Biol Ther"},{"issue":"44","key":"1984_CR5","doi-asserted-by":"publisher","first-page":"17073","DOI":"10.1073\/pnas.0806173105","volume":"105","author":"AJ Muller","year":"2008","unstructured":"Muller AJ, Sharma MD, Chandler PR, Duhadaway JB, Everhart ME, Johnson BA 3rd, et al. Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase. Proc Natl Acad Sci USA. 2008;105(44):17073\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"1984_CR6","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1158\/1078-0432.CCR-05-1966","volume":"12","author":"G Brandacher","year":"2006","unstructured":"Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res. 2006;12(4):1144\u201351.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1984_CR7","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1158\/1078-0432.CCR-07-4144","volume":"14","author":"K Ino","year":"2008","unstructured":"Ino K, Yamamoto E, Shibata K, Kajiyama H, Yoshida N, Terauchi M, et al. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival. Clin Cancer Res. 2008;14(8):2310\u20137.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"1984_CR8","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6603477","volume":"95","author":"K Ino","year":"2006","unstructured":"Ino K, Yoshida N, Kajiyama H, Shibata K, Yamamoto E, Kidokoro K, et al. Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer. Br J Cancer. 2006;95(11):1555\u201361.","journal-title":"Br J Cancer"},{"issue":"16","key":"1984_CR9","doi-asserted-by":"publisher","first-page":"6030","DOI":"10.1158\/1078-0432.CCR-04-2671","volume":"11","author":"A Okamoto","year":"2005","unstructured":"Okamoto A, Nikaido T, Ochiai K, Takakura S, Saito M, Aoki Y, et al. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells. Clin Cancer Res. 2005;11(16):6030\u20139.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1984_CR10","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/j.1349-7006.2007.00470.x","volume":"98","author":"T Nakamura","year":"2007","unstructured":"Nakamura T, Shima T, Saeki A, Hidaka T, Nakashima A, Takikawa O, et al. Expression of indoleamine 2,3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer. Cancer Sci. 2007;98(6):874\u201381.","journal-title":"Cancer Sci"},{"issue":"5","key":"1984_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jamcollsurg.2007.12.014","volume":"206","author":"A Witkiewicz","year":"2008","unstructured":"Witkiewicz A, Williams TK, Cozzitorto J, Durkan B, Showalter SL, Yeo CJ, et al. Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection. J Am Coll Surg. 2008;206(5):849\u201356.","journal-title":"J Am Coll Surg"},{"issue":"12","key":"1984_CR12","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.4161\/cc.8.12.8745","volume":"8","author":"JR Brody","year":"2009","unstructured":"Brody JR, Costantino CL, Berger AC, Sato T, Lisanti MP, Yeo CJ, et al. Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival. Cell Cycle. 2009;8(12):1930\u20134.","journal-title":"Cell Cycle"},{"issue":"5","key":"1984_CR13","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1111\/cas.13560","volume":"109","author":"A Seeber","year":"2018","unstructured":"Seeber A, Klinglmair G, Fritz J, Steinkohl F, Zimmer KC, Aigner F, et al. High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma. Cancer Sci. 2018;109(5):1583\u201391.","journal-title":"Cancer Sci"},{"issue":"3","key":"1984_CR14","doi-asserted-by":"publisher","first-page":"e23428","DOI":"10.4161\/onci.23428","volume":"2","author":"BC Creelan","year":"2013","unstructured":"Creelan BC, Antonia S, Bepler G, Garrett TJ, Simon GR, Soliman HH. Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer. Oncoimmunology. 2013;2(3):e23428.","journal-title":"Oncoimmunology."},{"issue":"3","key":"1984_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1158\/0008-5472.CAN-17-2995","volume":"78","author":"W Wang","year":"2018","unstructured":"Wang W, Huang L, Jin JY, Jolly S, Zang Y, Wu H, et al. IDO immune status after chemoradiation may predict survival in lung cancer patients. Cancer Res. 2018;78(3):809\u201316.","journal-title":"Cancer Res"},{"issue":"1","key":"1984_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12967-018-1595-3","volume":"16","author":"A Botticelli","year":"2018","unstructured":"Botticelli A, Cerbelli B, Lionetto L, Zizzari I, Salati M, Pisano A, et al. Can IDO activity predict primary resistance to anti-PD-1 treatment in NSCLC? J Transl Med. 2018;16(1):219.","journal-title":"J Transl Med."},{"issue":"5","key":"1984_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","volume":"22","author":"DH Munn","year":"2005","unstructured":"Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity. 2005;22(5):633\u201342.","journal-title":"Immunity"},{"issue":"1","key":"1984_CR18","doi-asserted-by":"publisher","first-page":"145","DOI":"10.4049\/jimmunol.0803277","volume":"183","author":"M Brenk","year":"2009","unstructured":"Brenk M, Scheler M, Koch S, Neumann J, Takikawa O, H\u00e4cker G, et al. Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+Foxp3+ T regulatory cells. J Immunol. 2009;183(1):145\u201354.","journal-title":"J Immunol."},{"issue":"4","key":"1984_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1084\/jem.20020052","volume":"196","author":"P Terness","year":"2002","unstructured":"Terness P, Bauer TM, R\u00f6se L, Dufter C, Watzlik A, Simon H, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med. 2002;196(4):447\u201357.","journal-title":"J Exp Med"},{"issue":"4","key":"1984_CR20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.20020121","volume":"196","author":"G Frumento","year":"2002","unstructured":"Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med. 2002;196(4):459\u201368.","journal-title":"J Exp Med"},{"issue":"5","key":"1984_CR21","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00262-013-1393-y","volume":"62","author":"H Soliman","year":"2013","unstructured":"Soliman H, Rawal B, Fulp J, Lee JH, Lopez A, Bui MM, et al. Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry. Cancer Immunol Immunother. 2013;62(5):829\u201337.","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"1984_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s13058-014-0410-1","volume":"16","author":"JY Chen","year":"2014","unstructured":"Chen JY, Li CF, Kuo CC, Tsai KK, Hou MF, Hung WC. Cancer\/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression. Breast Cancer Res. 2014;16(4):410.","journal-title":"Breast Cancer Res"},{"key":"1984_CR23","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1756-0500-4-156","volume":"4","author":"DE Lyon","year":"2011","unstructured":"Lyon DE, Walter JM, Starkweather AR, Schubert CM, McCain NL. Tryptophan degradation in women with breast cancer: a pilot study. BMC Res Notes. 2011;4:156.","journal-title":"BMC Res Notes."},{"issue":"1","key":"1984_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1158\/1541-7786.MCR-18-0362","volume":"17","author":"LI Greene","year":"2019","unstructured":"Greene LI, Bruno TC, Christenson JL, D\u2019Alessandro A, Culp-Hill R, Torkko K, et al. A role for tryptophane-2,3-dioxygenase in CD8 T cell suppression and evidence of tryptophan catabolism in breast cancer patient plasma. Mol Cancer Res. 2019;17(1):131\u20139.","journal-title":"Mol Cancer Res"},{"issue":"4","key":"1984_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s13058-014-0415-9","volume":"16","author":"X Tang","year":"2014","unstructured":"Tang X, Lin CC, Spasojevic I, Iversen ES, Chi JT, Marks JR. A joint analysis of metabolomics and genetics of breast cancer. Breast Cancer Res. 2014;16(4):415.","journal-title":"Breast Cancer Res"},{"issue":"21","key":"1984_CR26","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1158\/0008-5472.CAN-15-2011","volume":"75","author":"NC D\u2019Amato","year":"2015","unstructured":"D\u2019Amato NC, Rogers TJ, Gordon MA, Greene LI, Cochrane DR, Spoelstra NS, et al. A TDO2-AhR signaling axis facilitates anoikis resistance and metastasis in triple-negative breast cancer. Cancer Res. 2015;75(21):4651\u201364.","journal-title":"Cancer Res"},{"issue":"5","key":"1984_CR27","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jnc.13496","volume":"136","author":"J De Bie","year":"2016","unstructured":"De Bie J, Guest J, Guillemin GJ, Grant R. Central kynurenine pathway shift with age in women. J Neurochem. 2016;136(5):995\u20131003.","journal-title":"J Neurochem"},{"issue":"11","key":"1984_CR28","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1002\/jbmr.3224","volume":"32","author":"ME Refaey","year":"2017","unstructured":"Refaey ME, McGee-Lawrence ME, Fulzele S, Kennedy EJ, Bollag WB, Elsalanty M, et al. Kynurenine, a tryptophan metabolite that accumulates with age, induces bone loss. J Bone Miner Res. 2017;32(11):2182\u201393.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1984_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1200\/JCO.2009.23.7370","volume":"28","author":"C Denkert","year":"2010","unstructured":"Denkert C, Loibl S, Noske A, Roller M, M\u00fcller BM, Komor M, Budczies J, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol. 2010;28(1):105\u201313.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1984_CR30","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10549-011-1554-7","volume":"132","author":"M Ono","year":"2012","unstructured":"Ono M, Tsuda H, Shimizu C, Yamamoto S, Shibata T, Yamamoto H, et al. Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer. Breast Cancer Res Treat. 2012;132(3):793\u2013805.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-019-1984-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-019-1984-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T19:15:21Z","timestamp":1595358921000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-019-1984-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,23]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1984"],"URL":"https:\/\/doi.org\/10.1186\/s12967-019-1984-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,23]]},"assertion":[{"value":"16 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The institutional ethics committee of the University Hospital of Li\u00e8ge (Belgium) approved the protocols under the following committee\u2019s reference numbers: 2010\/252; 2013\/214 and 2013\/215.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Each patient or healthy control signed informed consent before inclusion in the trial, including acceptance for data publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}